3511 results for «2016年至2025年红利质量、中证红利、中证央企红利、红利低波每年收益对比»
3511 results
Intriguing cases in interventional cardiology
05 Oct 2024 – From AICT-AsiaPCR 2024
Delve into a diverse array of intriguing cardiology cases submitted to the AICT-AsiaPCR 2024 conference. Explore scenarios ranging from navigating coronary perforations, managing PCI in cardiogenic shock, and addressing rare vascular pathologies. This session offers a unique opportunity to learn from real-world experiences and expand your...
Navigating the challenges of calcified lesions
05 Oct 2024 – From AICT-AsiaPCR 2024
Delve into a collection of challenging cases focused on the management of calcified coronary lesions, submitted to the AICT-AsiaPCR 2024 conference. Discover innovative techniques and strategies for tackling heavily calcified vessels, including the use of specialized tools like intravascular lithotripsy and rotational atherectomy. Gain valuable insights...
Image-guided PCI of distal left main disease
05 Oct 2024 – From AICT-AsiaPCR 2024
Exploring a recorded case of image-guided PCI of distal left main disease, as well as a new paradigm in AI-driven imaging, and learn how coronary imaging aids in decision-making, optimises final outcomes, and enhances stent clarity to guide results in complex PCI procedures. Watch now to deepen...
Think SMART! Valve precision and performance matters
05 Oct 2024 – From AICT-AsiaPCR 2024
Explore the impact of the SMART trial results on your practice and decision-making in TAVI. Learn how to achieve precision and control in challenging anatomy with the Evolut FX Platform. Discover the new Evolut FX System and how it can deliver optimal procedural outcomes for all...
Complex calcified left main bifurcation - LIVE case
05 Oct 2024 – From AICT-AsiaPCR 2024
An 82-year-old woman with diabetes, hypertension, a history of Micra and RCA PCI 2 years later, was admitted for NSTEMI. The coronary angiography showed a very calcified distal left main stenosis, a significant and calcified ostial LAD stenosis (medina: 1 1 0), confirmed by IVUS. She...
Tips and tricks for left main PCI
05 Oct 2024 – From AICT-AsiaPCR 2024
Dive into this comprehensive session to learn essential tips and tricks for tackling left main PCI. Gain insights on managing thrombus at the left main and providing hemodynamic support in low-resource settings. Discover techniques to handle complex lesions at the left main, and learn how to...
Complex NSTEMI interventions: Bifurcation and calcification management strategies
05 Oct 2024 – From AICT-AsiaPCR 2024
Explore a diverse array of challenging NSTEMI cases in this session, curated from the AICT-AsiaPCR 2024 conference. Witness innovative approaches to managing bifurcation lesions, tackling calcified and complex coronary anatomy, and navigating double complications. Gain valuable insights from experienced interventionalists as they share their strategies for...
EuroPCR 2025 – The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI – 12-month follow-up data
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...
EuroPCR 2025 – One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...
Major EuroPCR 2025 LBT - 4D-ACS: one-month DAPT followed by dose reduction of prasugrel after drug-coated stent insertion in acute coronary syndrome
21 May 2025 – From EuroPCR 2025
In this EuroPCR 2025 interview, Davide Capodanno and Woong Chol Kang discuss antithrombotic therapy in patients with acute coronary syndromes, focusing on the design and outcomes of the 4D-ACS trial. They describe the patient population enrolled in the study and introduce the two de-escalation strategies investigated:...
Hotline from EuroPCR 2025 - Five-year outcomes from the Evolut low risk TAVR bicuspid study
21 May 2025 – From EuroPCR 2025
Simon Redwood and John Forrest exchange insights on the Evolut Low Risk Bicuspid Study, which explores transcatheter aortic valve replacement (TAVR) in younger, low-risk patients with bicuspid aortic valves—an anatomy often excluded from earlier trials.
They review the trial design, patient characteristics, and results, comparing outcomes with...
EuroPCR 2025: RESIL-Card achieves a major milestone - The resilience tool is ready for pilot testing!
20 May 2025
Launched in December 2023 by our community through the ‘We CARE Alliance’ and co-funded by the EU4Health work programme, the mission of the RESIL-Card project is to ensure that essential healthcare services for people with cardiovascular (CV) diseases are maintained during crises. Specifically, the project aims to...
SMT’s Supraflex Cruz shows consistent and robust clinical outcomes across key global studies presented at TCT 2025
29 Oct 2025
Jupiter Endovascular announces positive results from SPIRARE I first-in-human study presented at TCT 2025
26 Oct 2025
Meril Life Sciences presents one-year outcomes from the LANDMARK randomized controlled trial at PCR London Valves 2025
16 Nov 2025
Indirect Industry Supported Grants for #PCRLV
Programme's key features
Find out about the key elements of the 2016 Programme!
Useful links in Interventional Cardiology
12 Oct 2016
We would like to share useful information and links to resources with you on Interventional Cardiology, medical professional societies, specialised websites and scoring tools.
Major LBTs from EuroPCR 2025 - Meta-Analysis of individual patient data from the PROTECTED TAVR and BHF PROTECT-TAVI studies
22 May 2025 – From EuroPCR 2025
Stroke remains one of the most feared complications of TAVI—for both patients and physicians. In this EuroPCR 2025 video interview, Bernard Prendergast and Rajesh Kharbanda examine the role of cerebral protection during TAVI procedures, in light of two randomised trials: PROTECTED TAVR and BHF PROTECT-TAVI. While...
EuroPCR 2025: Late-breaking data demonstrate sustained significantly lower event rates with Elixir Medical’s DynamX® Bioadaptor over drug-eluting stent through three Years
21 May 2025